From: Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?
Case no. | Age | Sex | Diagnosis | Procedure for pancreatic tumor | Renal tumor | Procedure | Interval (months) | Phase | Follow-up (months) | outcome |
---|---|---|---|---|---|---|---|---|---|---|
1 | 70 | M | PDAC | ppWhipple | Clear cell RCC | Partial neph. | 0 | Synchronous | 35 | Alive |
2 | 72 | W | PDAC | ppWhipple | Clear cell RCC | nephrectomy | 94 | Metachronous | 14 | Dead |
3 | 70 | M | PDAC | ppWhipple | Clear cell RCC | Partial neph. | 0 | Synchronous | 5.25 | Dead |
4 | 68 | M | PDAC | Double bypass | RCC | Nephrectomy | 119 | Metachronous | 4 | Dead |
5 | 77 | W | PDAC | Total pancreatectomy | RCC | Nephrectomy | 152 | Metachronous | 12.25 | Dead |
6 | 68 | M | PDAC | Double bypass | RCC | Partial neph. | 205 | Metachronous | 13 | Dead |
7 | 77 | M | PDAC | Exploration | RCC | Nephrectomy | 94 | Metachronous | 2.25 | Dead |
8 | 71 | M | PDAC | ppWhippe | RCC | Partial neph. | 84 | Metachronous | 12.5 | Dead |
9 | 71 | M | PDAC | ppWhipple | Pap. RCC | nephrectomy | 0 | Synchronous | 3.25 | Dead |
10 | 68 | M | PDAC | Double bypass | RCC | Partial neph. | 135 | Metachronous | 0 | Dead |
11 | 55 | W | PDAC | Left resection | RCC | Nephrectomy | 135 | Metachronous | 17 | Alive |
12 | 52 | M | IPMN | ppWhipple | Cystic RCC | Partial neph. | 0 | Synchronous | 8 | Alive |
13 | 65 | W | IPMN | ppWhipple | RCC | Nephrectomy | 3 | Synchronous | 27.75 | Dead |
14 | 71 | M | IPMN | Total pancreatectomy | Pap. RCC | Partial neph. | 1.25 | Synchronous | 14 | Alive |
15 | 73 | M | IPMN | Total pancreatectomy | RCC | Partial neph. | 205 | Metachronous | 32 | Alive |
16 | 75 | M | PDAC | Gastroenterostomy | Pap. RCC | nephrectomy | 21 | Metachronous | 1.5 | Dead |